Tango Therapeutics Inc

TNGXNASDAQ · USD
24.63USD0.00 (+0.74%)
2110

Tango Therapeutics Inc (TNGX) Option Chain

As of September 23, 2026, Tango Therapeutics Inc is trading at $24.63, a +0.74% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 85.2%. IV Rank is 14%.

Read more

Tracking the TNGX option chain helps you see every strike and expiry on Tango Therapeutics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Tango Therapeutics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of TNGX options activity at a glance. Use our scanner to monitor the TNGX option chain in real time and filter for the TNGX options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For TNGX stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the TNGX option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where TNGX stock options are being actively traded and where they are not.

Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops Ubiquitin-specific protease 1, an inhibitor to treat patients with BRCA1 or BRCA2-mutant cancers; and Target 3 for STK11-mutant cancers. Tango Therapeutics, Inc. has a strategic collaboration with Gilead Sciences, Inc. for the discovery, development, and commercialization of a pipeline of therapies for patients with cancer.

The company was founded in 2017 and is based in Cambridge, Massachusetts.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Tango Therapeutics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen TNGX options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of TNGX stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile30.16% Subdued
  • Market cap (M$)4,153
  • 52 weeks high-28.38%
  • 52 weeks low268.16%
  • Analyst recommendationStrong Buy
    1.17
  • Target price$45.18
    83.43% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-03
  • P/E—
  • Future P/E—
  • EPS (ttm)-0.84
  • EPS growth next 5 years—

As of September 23, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
42.801101.651.631.854.7023.00-5.930.052.100.001.0802357.20
50.525501.850.631.253.7024.00-1.840.852.500.001.684549.48
57.9244502.000.001.202.8025.00+2.251.402.850.371.753330442.08
64.772301.250.000.551.9526.00+6.340.953.401.370.800035.23
70.941000.880.000.051.7027.00+10.432.104.302.370.830029.06

As of September 23, 2026

Scan the full option chain in one place

Browse the full TNGX option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial